Claritev (CTEV) Stock Price

Claritev Price

NYSE·CLOSED
25.73USD+0.14 (+0.55 %)
Market closed

Revenue at Claritev has contracted by 1.1% per year over the past 7 years to 965.41 M USD. Earnings per share have grown at 20.0% per year over the last 3 years. For Claritev, the net margin of -29.4% is down versus 9.1% a few years ago. The consensus 12-month price target for Claritev is 64.26 USD, about 149.7% above where the stock trades today. Of 11 analysts, 9 rate the stock a buy — an overall Buy consensus. Claritev's share price has gained 61.8% over the last twelve months. The stock trades about 345% above its 52-week low.

Claritev stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Claritev over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Claritev stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Claritev's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Claritev Stock Price History
DateClaritev Price
8/5/202625.73 USD
8/4/202625.59 USD
8/3/202624.29 USD
7/31/202622.71 USD
7/30/202623.58 USD
7/29/202623.33 USD
7/27/202622.49 USD
7/23/202623.27 USD
7/22/202624.98 USD
7/21/202628.69 USD
7/20/202630.12 USD
7/17/202630.39 USD
7/16/202630.76 USD
7/15/202629.44 USD
7/14/202628.36 USD
7/13/202631.08 USD
7/10/202631.24 USD
7/9/202632.90 USD
7/8/202631.96 USD
7/7/202631.62 USD
7/6/202631.65 USD
7/2/202632.64 USD
7/1/202632.40 USD
6/30/202634.11 USD
6/29/202633.82 USD
6/26/202633.15 USD
6/25/202634.72 USD
6/24/202630.49 USD
6/23/202630.06 USD
6/22/202629.09 USD
6/18/202629.42 USD
6/17/202629.75 USD
6/16/202630.67 USD
6/15/202630.61 USD
6/12/202630.89 USD
6/11/202632.03 USD
6/10/202627.92 USD
6/9/202628.35 USD
6/8/202627.07 USD
6/5/202625.84 USD
6/4/202627.57 USD
6/3/202626.27 USD
6/2/202628.34 USD
6/1/202626.99 USD
5/29/202625.12 USD
5/28/202624.56 USD
5/27/202623.07 USD
5/26/202621.76 USD
5/22/202621.67 USD
5/21/202623.55 USD
5/20/202621.24 USD
5/19/202616.20 USD
5/18/202616.42 USD
5/15/202613.87 USD
5/14/202613.87 USD
5/13/202613.67 USD
5/12/202614.14 USD
5/11/202614.69 USD
5/8/202613.38 USD
5/7/202612.00 USD
5/6/202613.12 USD
5/5/202613.07 USD
5/4/202612.54 USD
5/1/202612.35 USD
4/30/202612.06 USD
4/29/202611.43 USD
4/28/202611.64 USD
4/27/202612.00 USD
4/24/202611.80 USD
4/23/202610.06 USD
4/22/202610.86 USD
4/21/202610.53 USD
4/20/202611.12 USD
4/17/202610.20 USD
4/16/20269.74 USD
4/15/20269.42 USD
4/14/20268.99 USD
4/13/20268.61 USD
4/10/20268.05 USD
4/9/20268.86 USD
4/8/20268.64 USD
4/7/20268.38 USD
4/6/20268.45 USD
4/2/20268.65 USD
4/1/20268.34 USD
3/31/20268.10 USD
3/30/20267.83 USD
3/27/20267.70 USD
3/26/20267.90 USD
3/25/20267.70 USD
3/24/20267.61 USD
3/23/20267.66 USD
3/20/20267.38 USD
3/19/20267.60 USD
3/18/20268.07 USD
3/17/20268.38 USD
3/16/20268.72 USD
3/13/20268.37 USD
3/12/20267.94 USD
3/11/20268.32 USD
3/10/20268.09 USD
3/9/20268.31 USD
3/6/20268.53 USD
3/5/20268.78 USD
3/4/20268.83 USD
3/3/20268.38 USD
3/2/20267.15 USD
2/27/20266.67 USD
2/26/20267.02 USD
2/25/20267.34 USD
2/24/20266.72 USD
2/23/20266.72 USD
2/20/20266.74 USD
2/19/20266.75 USD
2/18/20266.82 USD
2/17/20266.69 USD
2/13/20266.65 USD
2/12/20265.78 USD
2/11/20266.02 USD
2/10/20266.39 USD
2/9/20266.89 USD
2/6/20267.50 USD
2/5/20267.44 USD
2/4/20267.29 USD
2/3/20267.52 USD
2/2/20268.04 USD
1/30/20267.86 USD
1/29/20267.80 USD
1/28/20267.81 USD
1/27/20267.83 USD
1/26/20268.19 USD
1/23/20268.35 USD
1/22/20268.70 USD
1/21/20268.35 USD
1/20/20268.25 USD
1/16/20268.81 USD
1/15/20268.70 USD
1/14/20268.82 USD
1/13/20269.38 USD
1/12/20269.25 USD
1/9/20268.38 USD
1/8/20269.03 USD
1/7/20269.46 USD
1/6/20269.18 USD
1/5/20268.55 USD
1/2/20269.81 USD
12/31/202512.37 USD
12/30/202512.57 USD
12/29/202512.28 USD
12/26/202512.17 USD
12/24/202512.36 USD
12/23/202512.09 USD
12/22/202512.40 USD
12/19/202511.87 USD
12/18/202511.90 USD
12/17/202511.12 USD
12/16/202511.10 USD
12/15/202510.99 USD
12/12/202510.84 USD
12/11/202511.28 USD
12/10/202510.13 USD
12/9/20259.84 USD
12/8/20259.55 USD
12/5/20259.83 USD
12/4/202510.70 USD
12/3/202511.56 USD
12/2/202513.04 USD
12/1/202513.55 USD
11/28/202515.65 USD
11/26/202515.88 USD
11/25/202515.11 USD
11/24/202513.92 USD
11/21/202513.64 USD
11/20/202513.09 USD
11/19/202513.47 USD
11/18/202512.24 USD
11/17/202511.04 USD
11/14/202512.52 USD
11/13/202512.79 USD
11/12/202516.97 USD
11/11/202516.57 USD
11/10/202516.74 USD
11/7/202520.05 USD
11/6/202517.94 USD
11/5/202518.82 USD
11/4/202518.20 USD
11/3/202518.84 USD
10/31/202518.84 USD
10/30/202519.12 USD
10/29/202519.86 USD
10/28/202520.60 USD
10/27/202520.66 USD
10/24/202520.17 USD
10/23/202519.23 USD
10/22/202519.13 USD
10/21/202519.11 USD
10/20/202516.94 USD
10/17/202516.00 USD
10/16/202516.36 USD
10/15/202516.23 USD
10/14/202516.00 USD
10/13/202515.17 USD
10/10/202515.55 USD
10/9/202516.88 USD
10/8/202516.60 USD
10/7/202516.10 USD
10/6/202514.76 USD
10/3/202514.79 USD
10/2/202513.43 USD
10/1/202513.99 USD
9/30/202515.37 USD
9/29/202515.23 USD
9/26/202514.89 USD
9/25/202514.43 USD
9/24/202515.24 USD
9/23/202514.91 USD
9/22/202514.91 USD
9/19/202514.97 USD
9/18/202516.03 USD
9/17/202516.16 USD
9/16/202516.52 USD
9/15/202517.33 USD
9/12/202517.80 USD
9/11/202517.84 USD
9/10/202518.29 USD
9/9/202520.97 USD
9/8/202520.89 USD
9/5/202520.21 USD
9/4/202519.59 USD
9/3/202519.79 USD
9/2/202520.07 USD
8/29/202519.95 USD
8/28/202520.64 USD
8/27/202520.80 USD
8/26/202521.01 USD
8/25/202520.73 USD
8/22/202520.89 USD
8/21/202519.88 USD
8/20/202519.13 USD
8/19/202519.60 USD
8/18/202520.90 USD
8/15/202520.73 USD
8/14/202519.63 USD
8/13/202520.37 USD
8/12/202519.02 USD
8/11/202517.83 USD
8/8/202516.44 USD
8/7/202515.90 USD
Access this data via the Eulerpool API
Get Free API Key

Claritev Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
1.12 B USD
386.12 M USD
102.08 M USD
Jan 1, 2022
1.08 B USD
-260.84 M USD
-572.91 M USD
Jan 1, 2023
961.52 M USD
161.98 M USD
-91.70 M USD
Jan 1, 2024
930.62 M USD
-1.44 B USD
-1.65 B USD
Jan 1, 2025
965.41 M USD
45.06 M USD
-284.28 M USD
Jan 1, 2026 (e)
993.39 M USD
-122.12 M USD
-261.76 M USD
Jan 1, 2027 (e)
1.04 B USD
-127.63 M USD
-228.03 M USD
Jan 1, 2028 (e)
1.08 B USD
-132.70 M USD
-214.50 M USD

Claritev Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 1:32 PM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
SHARESM
201820192020202120222023202420252026e2027e2028e
1.040.980.941.121.080.960.930.970.991.041.08
–-5.58-4.5819.21-3.40-10.94-3.233.762.904.533.95
85.6784.8366.0684.3381.0975.5574.3027.5627.5627.5627.56
891.00833.00619.00942.00875.00726.00691.00266.00273.72286.12297.42
0.430.37-0.130.39-0.260.16-1.440.05-0.12-0.13-0.13
41.0637.47-13.9834.56-24.1016.75-155.274.66-12.29-12.24-12.23
0.040.01-0.520.10-0.57-0.09-1.65-0.28-0.26-0.23-0.21
–-75.00-5,877.78-119.62-660.78-84.091,707.69-82.74-8.10-12.64-6.14
10.0010.0011.7716.2915.9716.1316.1516.4316.4316.4316.43
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Claritev generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Claritev retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Claritev's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Claritev has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Claritev's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Claritev stock margins

The Claritev margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Claritev. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Claritev.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
84.32 %
34.55 %
9.13 %
Jan 1, 2022
81.10 %
-24.16 %
-53.06 %
Jan 1, 2023
75.51 %
16.85 %
-9.54 %
Jan 1, 2024
74.27 %
-155.20 %
-176.85 %
Jan 1, 2025
27.61 %
4.67 %
-29.45 %
Jan 1, 2026 (e)
27.61 %
-12.29 %
-26.35 %
Jan 1, 2027 (e)
27.61 %
-12.29 %
-21.96 %
Jan 1, 2028 (e)
27.61 %
-12.29 %
-19.87 %

Claritev Stock Revenue, EBIT, Earnings per Share

The Claritev earnings per share therefore indicates how much revenue Claritev has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
68.61 USD
23.71 USD
6.27 USD
Jan 1, 2022
67.60 USD
-16.33 USD
-35.87 USD
Jan 1, 2023
59.62 USD
10.04 USD
-5.69 USD
Jan 1, 2024
57.63 USD
-89.45 USD
-101.92 USD
Jan 1, 2025
58.74 USD
2.74 USD
-17.30 USD
Jan 1, 2026 (e)
60.44 USD
-7.43 USD
-15.93 USD
Jan 1, 2027 (e)
63.17 USD
-7.77 USD
-13.87 USD
Jan 1, 2028 (e)
65.68 USD
-8.07 USD
-13.05 USD

Claritev business model & stock analysis

Claritev Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Claritev historical P/E ratio, EBIT multiple, and P/S ratio

Claritev annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Claritev shares outstanding

The number of shares of Claritev was 16.43 M in 2025. This indicates how many shares Claritev is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
16.29 M Stocks
Jan 1, 2022
15.97 M Stocks
Jan 1, 2023
16.13 M Stocks
Jan 1, 2024
16.15 M Stocks
Jan 1, 2025
16.43 M Stocks
Jan 1, 2026 (e)
16.43 M Stocks
Jan 1, 2027 (e)
16.43 M Stocks
Jan 1, 2028 (e)
16.43 M Stocks

Claritev stock splits

In Claritev's history, there have been no stock splits.

Current Claritev forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
81.82 % (9)
Hold
18.18 % (2)
Sell
0.00 % (0)
12M Price Target
64.26
Last Price
26.84
Currency
USD
12M Return Potential
139.42 %
LTM Return
0 %

Claritev Analyst Rating Actions

DateFirmActionRatingReliability
7/21/2026
Canaccord Genuity
Canaccord Genuity
MaintainedBuy59
3/19/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
2/25/2026
Citigroup
Citigroup
MaintainedBuy48
2/24/2026
Wells Fargo
Wells Fargo
MaintainedEqual Weight56
2/24/2026
Guggenheim
Guggenheim
MaintainedBuy30
1/9/2026
Citigroup
Citigroup
MaintainedBuy48
11/10/2025
Citigroup
Citigroup
MaintainedBuy48
10/22/2025
Citigroup
Citigroup
UpgradeNeutralBuy48
10/21/2025
Citigroup
Citigroup
UpgradeNeutralBuy48
8/15/2025
Piper Sandler
Piper Sandler
MaintainedOverweight51

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Claritev Earnings Calls

2025

Claritev Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/7/2026-4.21USD-249.71 MUSD-2026 Q2
5/7/2026-4.09USD-241.12 MUSD-2026 Q1
2/23/2026-3.88USD-245.85 MUSD-2025 Q4

EESG©

Eulerpool ESG Scorecard© for the Claritev stock

41/100
27
Environment
75
Social
20
Governance
E

Environment

20
Scope 1 - Direct Emissions0.11
Scope 2 - Indirect emissions from purchased energy10,851
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions10,851
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees70
Percentage of women in management—
Percentage of Asian employees14
Share of Asian management16
Percentage of Hispanic/Latino employees11
Hispano/Latino Management share9
Percentage of Black employees18
Black Management Share4
Percentage of white employees53
White Management Share68
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Claritev shareholder structure

% Name
23.65611%
Hellman & Friedman LLC
Hellman & Friedman LLC
11.33627%
Ares Management LLC
Ares Management LLC
9.15060%
Arini Capital Management Limited
Arini Capital Management Limited
7.79591%
Public Investment Fund
Public Investment Fund
4.59389%
Beach Point Capital Management, LP
Beach Point Capital Management, LP
3.54069%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
...

Claritev Beneficial Ownership Filings (SEC 13D/G)

Free Float
42.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
23.50%
H&F Corporate Investors VIII, Ltd.
H&F Corporate Investors VIII, Ltd.
SEC ↗
23.50%
Hellman & Friedman Investors VIII, L.P.
Hellman & Friedman Investors VIII, L.P.
SEC ↗
16.40%
Hellman & Friedman Capital Partners VIII, L.P.
Hellman & Friedman Capital Partners VIII, L.P.
SEC ↗
9.11%
Arini Capital Management Limited
Arini Capital Management Limited
SEC ↗
5.50%
Hellman & Friedman Capital Partners VIII (Parallel), L.P.
Hellman & Friedman Capital Partners VIII (Parallel), L.P.
SEC ↗
4.10%
H&F Polaris Partners, L.P.
H&F Polaris Partners, L.P.
SEC ↗
4.10%
H&F Polaris Partners GP, LLC
H&F Polaris Partners GP, LLC
SEC ↗
1.30%
HFCP VIII (Parallel - A), L.P.
HFCP VIII (Parallel - A), L.P.
SEC ↗
0.30%
Music Investments, L.P.
Music Investments, L.P.
SEC ↗
0.30%
Music Investments GP, LLC
Music Investments GP, LLC
SEC ↗

Claritev Executives and Management Board

19 members · avg. age 58 · 21 % women

TD

Mr. Travis Dalton (54)

Chairman of the Board, President, Chief Executive Officer · since 2024

11.73 M USD

Management

JH

Mr. Jerome Hogge (59)

Chief Operating Officer, Executive Vice President

2.54 M USD
DG

Mr. Douglas Garis (40)

Chief Financial Officer, Executive Vice President

2.33 M USD
MK

Mr. Michael Kim (59)

Executive Vice President, Chief Digital Officer

1.33 M USD
TM

Ms. Tiffani Misencik (52)

Senior Vice President, Chief Growth Officer

1.17 M USD
CN

Ms. Carol Nutter (48)

Chief People Officer, Senior Vice President

1.10 M USD
BA

Mr. Brock Albinson (50)

Senior Vice President, Chief Accounting Officer

–

Board of Directors

DW

Mr. Dale White (69)

Director · since 2020

1.51 M USD
AC

Mr. Anthony Colaluca (58)

Independent Director

235,000.00 USD
JK

Ms. Julie Klapstein (70)

Independent Director

222,500.00 USD
RC

Mr. Richard Clarke (74)

Independent Director

220,000.00 USD
JP

Mr. John Prince (57)

Independent Director

212,500.00 USD
CH

Dr. C. Martin Harris (68)

Independent Director

210,000.00 USD

Frequently asked questions about Claritev

Analysts currently set an average price target of 66.10 USD for the Claritev stock (median: 64.26 USD), implying +146.3 % versus the latest price. The consensus is based on 11 analyst ratings.

Claritev Analyst Price Targets 2026

11 analysts currently rate the Claritev stock: 9 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Claritev to generate revenue of 993.39 M USD and earnings per share of -15.93 USD.

Claritev Analyst Price Targets 2026

Converted at the current exchange rate, the Claritev share trades at 22.32 EUR (25.73 USD).

The Claritev share (CTEV) is listed on 1 stock exchanges, including: NYSE (MPLN).

No history available for Claritev.

The expected revenue of Claritev is 993.39 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Claritev is -261.76 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Claritev is currently -1.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Claritev stock.

The price-to-sales ratio (P/S) of Claritev is currently 0.43. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Claritev stock.

The Eulerpool Quality Score for Claritev is 1/10.

The ISIN of Claritev is US62548M2098. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Claritev is CTEV. The ticker symbol is used to trade Claritev shares on the stock exchange.

Claritev paid dividends every year for the past 0 years.

Claritev is assigned to the 'Health' sector.

The dividends of Claritev are distributed in USD.

All fundamentals and in-depth analysis of Claritev

Our stock analysis for Claritev stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Claritev. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Claritev Stock
Claritev Revenue→
Claritev Stock
Claritev Net Income→
Claritev Stock
Claritev P/E→
Claritev Stock
Claritev P/S→
Claritev Stock
Claritev EBIT→
Claritev Stock
Claritev Dividend→
Claritev Stock
Claritev Directors Dealings→
Claritev Stock
Claritev Stocks→
Claritev Stock
Claritev Market capitalization→
Claritev Stock
Claritev Debt→
Claritev Stock
Claritev Liabilities→
Claritev Stock
Claritev Equity→
Claritev Stock
Claritev AAQS→
Claritev Stock
Claritev Employees→
Claritev Stock
Claritev ROE→
Claritev Stock
Claritev ROA→
Claritev Stock
Claritev ROCE→
Claritev Stock
Claritev News→
Claritev Stock
Claritev Analyst Price Targets→

Health Stocks

Clarity Medical Group HoldingClarianeClarity PharmaceuticalsClal Biotechnology IndustriesClassysCKD BioCleanspace HoldingsCJ BioscienceClearbridge HealthCizzle Biotechnology HoldingsClearmind MedicineCity View Green HoldingsAll Stocks A–Z →